Glutathionylation of the p50 subunit of NF-kappaB: a mechanism for redox-induced inhibition of DNA binding.

PubWeight™: 2.07‹?› | Rank: Top 2%

🔗 View Article (PMID 11714266)

Published in Biochemistry on November 27, 2001

Authors

E Pineda-Molina1, P Klatt, J Vázquez, A Marina, M García de Lacoba, D Pérez-Sala, S Lamas

Author Affiliations

1: Departamento de Estructura y Función de Proteínas, Centro de Investigaciones Biológicas, Instituto Reina Sofía de Investigaciones Nefrológicas, Madrid, Spain.

Articles citing this

(truncated to the top 100)

Redox regulation of cell survival. Antioxid Redox Signal (2008) 4.33

Crosstalk of reactive oxygen species and NF-κB signaling. Cell Res (2010) 3.71

Redox-based regulation of signal transduction: principles, pitfalls, and promises. Free Radic Biol Med (2008) 3.38

Molecular mechanisms and clinical implications of reversible protein S-glutathionylation. Antioxid Redox Signal (2008) 2.67

ROS and p53: a versatile partnership. Free Radic Biol Med (2008) 2.52

Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta. Proc Natl Acad Sci U S A (2006) 2.51

Endogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein. J Clin Invest (2003) 2.41

Beyond oxidative stress: an immunologist's guide to reactive oxygen species. Nat Rev Immunol (2013) 2.31

NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology. Antioxid Redox Signal (2009) 2.29

Basic principles and emerging concepts in the redox control of transcription factors. Antioxid Redox Signal (2011) 1.82

Functional site profiling and electrostatic analysis of cysteines modifiable to cysteine sulfenic acid. Protein Sci (2008) 1.54

Oxidative stress inhibits MEKK1 by site-specific glutathionylation in the ATP-binding domain. Biochem J (2004) 1.54

S-glutathionylation: from molecular mechanisms to health outcomes. Antioxid Redox Signal (2011) 1.49

NFkappaB promotes inflammation, coagulation, and fibrosis in the aging glomerulus. J Am Soc Nephrol (2010) 1.49

Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling. Antioxid Redox Signal (2013) 1.48

Human p53 is inhibited by glutathionylation of cysteines present in the proximal DNA-binding domain during oxidative stress. Biochemistry (2007) 1.43

Glutaredoxin-1 attenuates S-glutathionylation of the death receptor fas and decreases resolution of Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med (2014) 1.40

The Pseudomonas aeruginosa multidrug efflux regulator MexR uses an oxidation-sensing mechanism. Proc Natl Acad Sci U S A (2008) 1.39

The redox biochemistry of protein sulfenylation and sulfinylation. J Biol Chem (2013) 1.30

Regulation by reversible S-glutathionylation: molecular targets implicated in inflammatory diseases. Mol Cells (2008) 1.26

HSV infection induces production of ROS, which potentiate signaling from pattern recognition receptors: role for S-glutathionylation of TRAF3 and 6. PLoS Pathog (2011) 1.26

Modulation of glutaredoxin-1 expression in a mouse model of allergic airway disease. Am J Respir Cell Mol Biol (2006) 1.25

Targeted disruption of the glutaredoxin 1 gene does not sensitize adult mice to tissue injury induced by ischemia/reperfusion and hyperoxia. Free Radic Biol Med (2007) 1.25

Glutathione: new roles in redox signaling for an old antioxidant. Front Pharmacol (2014) 1.25

S-glutathionylation impairs signal transducer and activator of transcription 3 activation and signaling. Endocrinology (2008) 1.23

The role of glutathione S-transferase P in signaling pathways and S-glutathionylation in cancer. Free Radic Biol Med (2011) 1.22

Protein-thiol oxidation and cell death: regulatory role of glutaredoxins. Antioxid Redox Signal (2012) 1.20

Short interfering RNA-mediated silencing of glutaredoxin 2 increases the sensitivity of HeLa cells toward doxorubicin and phenylarsine oxide. Proc Natl Acad Sci U S A (2004) 1.16

Scientific and clinical challenges in sepsis. Curr Pharm Des (2009) 1.14

Manganese porphyrin, MnTE-2-PyP5+, Acts as a pro-oxidant to potentiate glucocorticoid-induced apoptosis in lymphoma cells. Free Radic Biol Med (2012) 1.12

A reducing redox environment promotes C2C12 myogenesis: implications for regeneration in aged muscle. Cell Biol Int (2006) 1.11

Ablation of glutaredoxin-1 attenuates lipopolysaccharide-induced lung inflammation and alveolar macrophage activation. Am J Respir Cell Mol Biol (2010) 1.10

Prospective type 1 and type 2 disulfides of Keap1 protein. Chem Res Toxicol (2008) 1.09

Dysfunction of Nrf-2 in CF epithelia leads to excess intracellular H2O2 and inflammatory cytokine production. PLoS One (2008) 1.08

Inhibition of caspase-3 activity and activation by protein glutathionylation. Biochem Pharmacol (2008) 1.08

Glutathione disulfide induces neural cell death via a 12-lipoxygenase pathway. Cell Death Differ (2009) 1.06

Manganese superoxide dismutase: beyond life and death. Amino Acids (2010) 1.06

Formation, reactivity, and detection of protein sulfenic acids. Chem Res Toxicol (2010) 1.05

Regulation of cell physiology and pathology by protein S-glutathionylation: lessons learned from the cardiovascular system. Antioxid Redox Signal (2012) 1.03

Multiple functions of Nm23-H1 are regulated by oxido-reduction system. PLoS One (2009) 1.02

Reactive oxygen species, nutrition, hypoxia and diseases: Problems solved? Redox Biol (2015) 1.02

Glutathione redox control of asthma: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal (2012) 1.01

Redox-based regulation of apoptosis: S-glutathionylation as a regulatory mechanism to control cell death. Antioxid Redox Signal (2011) 1.01

A noncanonical auxin-sensing mechanism is required for organ morphogenesis in Arabidopsis. Genes Dev (2016) 1.01

Glutaredoxin regulates autocrine and paracrine proinflammatory responses in retinal glial (muller) cells. J Biol Chem (2008) 1.00

Protein S-glutathiolation: redox-sensitive regulation of protein function. J Mol Cell Cardiol (2011) 0.99

S-glutathionylation of IRF3 regulates IRF3-CBP interaction and activation of the IFN beta pathway. EMBO J (2008) 0.99

Glutathionylation in the photosynthetic model organism Chlamydomonas reinhardtii: a proteomic survey. Mol Cell Proteomics (2011) 0.96

Protocols for the detection of s-glutathionylated and s-nitrosylated proteins in situ. Methods Enzymol (2010) 0.96

Proteomic identification and quantification of S-glutathionylation in mouse macrophages using resin-assisted enrichment and isobaric labeling. Free Radic Biol Med (2013) 0.95

Multiple cis-regulatory elements and the yeast sulphur regulatory network are required for the regulation of the yeast glutathione transporter, Hgt1p. Curr Genet (2005) 0.95

Glutaredoxin 1 regulates cigarette smoke-mediated lung inflammation through differential modulation of I{kappa}B kinases in mice: impact on histone acetylation. Am J Physiol Lung Cell Mol Physiol (2010) 0.94

S-glutathionylation regulates inflammatory activities of S100A9. J Biol Chem (2010) 0.93

Oxidative stress function of the Saccharomyces cerevisiae Skn7 receiver domain. Eukaryot Cell (2009) 0.91

Radical decisions in cancer: redox control of cell growth and death. Cancers (Basel) (2012) 0.90

Activation of the glutaredoxin-1 gene by nuclear factor κB enhances signaling. Free Radic Biol Med (2011) 0.90

Glutathione synthesis and its role in redox signaling. Semin Cell Dev Biol (2012) 0.90

Mitochondrial superoxide dismutase--signals of distinction. Anticancer Agents Med Chem (2011) 0.90

Redox control of microglial function: molecular mechanisms and functional significance. Antioxid Redox Signal (2014) 0.90

Mitochondria and reactive oxygen species: physiology and pathophysiology. Int J Mol Sci (2013) 0.89

Glutaredoxin-1 up-regulation induces soluble vascular endothelial growth factor receptor 1, attenuating post-ischemia limb revascularization. J Biol Chem (2014) 0.88

Prediction of S-glutathionylation sites based on protein sequences. PLoS One (2013) 0.88

Histone h3 glutathionylation in proliferating mammalian cells destabilizes nucleosomal structure. Antioxid Redox Signal (2013) 0.87

Salidroside stimulates mitochondrial biogenesis and protects against H₂O₂-induced endothelial dysfunction. Oxid Med Cell Longev (2014) 0.87

Heat shock proteins and hormesis in the diagnosis and treatment of neurodegenerative diseases. Immun Ageing (2015) 0.86

Attenuated cardiovascular hypertrophy and oxidant generation in response to angiotensin II infusion in glutaredoxin-1 knockout mice. Free Radic Biol Med (2010) 0.86

Cerebral nitric oxide represses choroid plexus NFκB-dependent gateway activity for leukocyte trafficking. EMBO J (2015) 0.86

Nutritional countermeasures targeting reactive oxygen species in cancer: from mechanisms to biomarkers and clinical evidence. Antioxid Redox Signal (2013) 0.86

Watching the watcher: regulation of p53 by mitochondria. Future Oncol (2009) 0.85

Genetic ablation of glutaredoxin-1 causes enhanced resolution of airways hyperresponsiveness and mucus metaplasia in mice with allergic airways disease. Am J Physiol Lung Cell Mol Physiol (2012) 0.85

Reduced glutathione: a radioprotector or a modulator of DNA-repair activity? Nutrients (2013) 0.85

Nitrosothiols in the immune system: signaling and protection. Antioxid Redox Signal (2012) 0.84

Regulation of apoptosis through cysteine oxidation: implications for fibrotic lung disease. Ann N Y Acad Sci (2010) 0.84

Impaired glutathione synthesis in neurodegeneration. Int J Mol Sci (2013) 0.84

Reactive oxygen and nitrogen species in steatotic hepatocytes: a molecular perspective on the pathophysiology of ischemia-reperfusion injury in the fatty liver. Antioxid Redox Signal (2014) 0.84

Redox Signaling by the RNA Polymerase III TFIIB-Related Factor Brf2. Cell (2015) 0.83

Protein glutathionylation in cardiovascular diseases. Int J Mol Sci (2013) 0.83

Plumbagin, a vitamin K3 analogue, abrogates lipopolysaccharide-induced oxidative stress, inflammation and endotoxic shock via NF-κB suppression. Inflammation (2014) 0.83

Rapid loss of adiponectin-stimulated fatty acid oxidation in skeletal muscle of rats fed a high fat diet is not due to altered muscle redox state. PLoS One (2012) 0.82

S-nitrosoglutathione-mediated STAT3 regulation in efficacy of radiotherapy and cisplatin therapy in head and neck squamous cell carcinoma. Redox Biol (2015) 0.79

Degradation of NF-κB, p53 and other regulatory redox-sensitive proteins by thiol-conjugating and -nitrosylating drugs in human tumor cells. Carcinogenesis (2013) 0.79

"Oxygen Sensing" by Na,K-ATPase: These Miraculous Thiols. Front Physiol (2016) 0.79

Investigating the potential for interaction between the components of PM(10). Environ Health Prev Med (2003) 0.79

Preclinical pharmacokinetic analysis of NOV-002, a glutathione disulfide mimetic. Biomed Pharmacother (2010) 0.78

Copper is a potent inhibitor of both the canonical and non-canonical NFκB pathways. Cell Cycle (2014) 0.78

Protective effect of verbascoside in activated C6 glioma cells: possible molecular mechanisms. Naunyn Schmiedebergs Arch Pharmacol (2009) 0.78

Regulation of neovascularization by S-glutathionylation via the Wnt5a/sFlt-1 pathway. Biochem Soc Trans (2014) 0.77

The glutaredoxin/S-glutathionylation axis regulates interleukin-17A-induced proinflammatory responses in lung epithelial cells in association with S-glutathionylation of nuclear factor κB family proteins. Free Radic Biol Med (2014) 0.77

Proteome analysis of proliferative response of bystander cells adjacent to cells exposed to ionizing radiation. Proteomics (2007) 0.77

Biological chemistry and functionality of protein sulfenic acids and related thiol modifications. Free Radic Res (2015) 0.77

Glutathione S-transferase pi modulates NF-κB activation and pro-inflammatory responses in lung epithelial cells. Redox Biol (2016) 0.77

Temporal changes in glutaredoxin 1 and protein s-glutathionylation in allergic airway inflammation. PLoS One (2015) 0.76

Oncogenic STAT5 signaling promotes oxidative stress in chronic myeloid leukemia cells by repressing antioxidant defenses. Oncotarget (2017) 0.76

Development of 'Redox Arrays' for identifying novel glutathionylated proteins in the secretome. Sci Rep (2015) 0.76

Endothelial Cell Redox Regulation of Ischemic Angiogenesis. J Cardiovasc Pharmacol (2016) 0.76

Glutathione adducts induced by ischemia and deletion of glutaredoxin-1 stabilize HIF-1α and improve limb revascularization. Proc Natl Acad Sci U S A (2016) 0.75

From structure to redox: the diverse functional roles of disulfides and implications in disease. Proteomics (2017) 0.75

S-Glutathionylation and Redox Protein Signaling in Drug Addiction. Prog Mol Biol Transl Sci (2015) 0.75

Redox regulation of ischemic limb neovascularization - What we have learned from animal studies. Redox Biol (2017) 0.75

Glutathionylation of the L-type Ca2+ channel in oxidative stress-induced pathology of the heart. Int J Mol Sci (2014) 0.75

Articles by these authors

Nitrosylation. the prototypic redox-based signaling mechanism. Cell (2001) 5.38

Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress. Eur J Biochem (2000) 2.96

Defective smooth muscle regulation in cGMP kinase I-deficient mice. EMBO J (1998) 2.96

Ca2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem J (1992) 2.68

Involvement of Rho GTPases in the transcriptional inhibition of preproendothelin-1 gene expression by simvastatin in vascular endothelial cells. Circ Res (2000) 2.42

Meningococcal disease in a large urban population (Barcelona, 1987-1992): predictors of dismal prognosis. Barcelona Meningococcal Disease Surveillance Group. Arch Intern Med (1999) 2.40

Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J Clin Invest (1998) 2.39

Mortality in second and third degree malnutrition. 1956. Bull World Health Organ (2000) 2.21

Prognostic factors in meningococcal disease. Development of a bedside predictive model and scoring system. Barcelona Meningococcal Disease Surveillance Group. JAMA (1997) 2.13

Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS Lett (1992) 1.79

Malignant colorectal obstruction treated by means of self-expanding metallic stents: effectiveness before surgery and in palliation. Radiology (2000) 1.76

15-Deoxy-Delta 12,14-prostaglandin J2 inhibition of NF-kappaB-DNA binding through covalent modification of the p50 subunit. J Biol Chem (2001) 1.75

Redox regulation of c-Jun DNA binding by reversible S-glutathiolation. FASEB J (1999) 1.66

Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene. FEBS Lett (1998) 1.64

A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nat Genet (1998) 1.63

Study of matrix metalloproteinases and their inhibitors in breast cancer. Br J Cancer (2007) 1.63

Phenotypic and genetic characterization of Lactococcus garvieae isolated in Spain from lactococcosis outbreaks and comparison with isolates of other countries and sources. J Clin Microbiol (2000) 1.53

Presence of nitric oxide synthase activity in roots and nodules of Lupinus albus. FEBS Lett (1996) 1.49

Native and oxidized low density lipoproteins oppositely modulate the effects of insulin-like growth factor I on VSMC. Cardiovasc Res (2004) 1.47

Betaine homocysteine S-methyltransferase: just a regulator of homocysteine metabolism? Cell Mol Life Sci (2006) 1.43

[Clinical utility of serous tumoural markers]. Aten Primaria (2003) 1.38

Kinetics and mechanism of tetrahydrobiopterin-induced oxidation of nitric oxide. J Biol Chem (1995) 1.37

Structure and function of cGMP-dependent protein kinases. Rev Physiol Biochem Pharmacol (1999) 1.34

Molecular mechanisms of inhibition of porcine brain nitric oxide synthase by the antinociceptive drug 7-nitro-indazole. Neuropharmacology (1994) 1.28

Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse. Br J Cancer (2007) 1.27

The porcine 2A10 antigen is homologous to human CD163 and related to macrophage differentiation. J Immunol (1999) 1.25

Increased adhesion and aggregation of platelets lacking cyclic guanosine 3',5'-monophosphate kinase I. J Exp Med (1999) 1.24

Identifying the recognition unit for G protein methylation. J Biol Chem (1991) 1.22

Release of nitric oxide from donors with known half-life: a mathematical model for calculating nitric oxide concentrations in aerobic solutions. Naunyn Schmiedebergs Arch Pharmacol (1997) 1.19

Ultra fast trypsin digestion of proteins by high intensity focused ultrasound. J Proteome Res (2005) 1.18

Mitochondrial DNA depletion: mutations in thymidine kinase gene with myopathy and SMA. Neurology (2002) 1.14

Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene. Hum Mol Genet (1998) 1.13

Time-resolved electrochromism associated with the formation of quinone anions in the Rhodobacter sphaeroides R26 reaction center. Biochemistry (1996) 1.10

Characterization of endothelial cell amino acid transport systems involved in the actions of nitric oxide synthase inhibitors. Mol Pharmacol (1993) 1.07

Novel application of S-nitrosoglutathione-Sepharose to identify proteins that are potential targets for S-nitrosoglutathione-induced mixed-disulphide formation. Biochem J (2000) 1.06

Apoptosis induced by IL-2 withdrawal is associated with an intracellular acidification. Exp Cell Res (1995) 1.06

Rapid detection of Chlamydia trachomatis. Lancet (1984) 1.05

Expression of mTert in primary murine cells links the growth-promoting effects of telomerase to transforming growth factor-beta signaling. Oncogene (2006) 1.05

Peroxynitrite-induced accumulation of cyclic GMP in endothelial cells and stimulation of purified soluble guanylyl cyclase. Dependence on glutathione and possible role of S-nitrosation. J Biol Chem (1995) 1.02

Expression of rat brain nitric oxide synthase in baculovirus-infected insect cells and characterization of the purified enzyme. Biochem J (1994) 1.02

Identification of the amino acid sequences responsible for high affinity activation of cGMP kinase Ialpha. J Biol Chem (1997) 1.02

[Meningococcal meningitis in Spain (1978-1981). III. Susceptibility of the meningococcal strains isolated from patients and carriers to the main agents used in the treatment and chemoprophylaxis of meningococcal infections]. Rev Sanid Hig Publica (Madr) (1984) 1.01

Genetic diversity of penicillin-resistant Neisseria meningitidis. J Infect Dis (1992) 1.01

Role of reactive oxygen species in the signalling cascade of cyclosporine A-mediated up-regulation of eNOS in vascular endothelial cells. Br J Pharmacol (1998) 1.01

Nitric oxide inhibits c-Jun DNA binding by specifically targeted S-glutathionylation. J Biol Chem (1999) 1.00

Induction of NO synthase in rat cardiac microvascular endothelial cells by IL-1 beta and IFN-gamma. Am J Physiol (1995) 0.99

Long-term potentiation in the hippocampal CA1 region of mice lacking cGMP-dependent kinases is normal and susceptible to inhibition of nitric oxide synthase. J Neurosci (1999) 0.98

Posttranscriptional regulation of human iNOS by the NO/cGMP pathway. Am J Physiol Renal Physiol (2001) 0.97

Nitric oxide production in arterial vessels of cirrhotic rats. Hepatology (1995) 0.97

Comparative analysis and clinical value of the expression of metalloproteases and their inhibitors by intratumor stromal fibroblasts and those at the invasive front of breast carcinomas. Breast Cancer Res Treat (2009) 0.96

Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites. Hepatology (1996) 0.95

[Neurologic manifestations of dissecting aneurysms of the aorta]. Med Clin (Barc) (1989) 0.95

Uptake of nitric oxide synthase inhibitors by macrophage RAW 264.7 cells. Biochem J (1994) 0.95

Solution structure of Taxotere-induced microtubules to 3-nm resolution. The change in protofilament number is linked to the binding of the taxol side chain. J Biol Chem (1994) 0.95

Bcl-2 differentially targets K-, N-, and H-Ras to mitochondria in IL-2 supplemented or deprived cells: implications in prevention of apoptosis. Oncogene (1999) 0.95

Transcription factor AP-2 activity is modulated by protein kinase A-mediated phosphorylation. FEBS Lett (1999) 0.94

A porcine cell surface receptor identified by monoclonal antibodies to SWC3 is a member of the signal regulatory protein family and associates with protein-tyrosine phosphatase SHP-1. Tissue Antigens (2000) 0.94

Large-scale purification of rat brain nitric oxide synthase from baculovirus overexpression system. Methods Enzymol (1996) 0.92

Overexpression of neuronal nitric oxide synthase in insect cells reveals requirement of haem for tetrahydrobiopterin binding. Biochem J (1996) 0.92

[New approach in the surgical treatment of the urogenital sinus]. Cir Pediatr (2000) 0.92

Regulation of neuronal nitric oxide and cyclic GMP formation by Ca2+. J Neurochem (1992) 0.92

Identification of imidazole as L-arginine-competitive inhibitor of porcine brain nitric oxide synthase. FEBS Lett (1994) 0.92

The 1.5 A resolution crystal structure of the carbamate kinase-like carbamoyl phosphate synthetase from the hyperthermophilic Archaeon pyrococcus furiosus, bound to ADP, confirms that this thermostable enzyme is a carbamate kinase, and provides insight into substrate binding and stability in carbamate kinases. J Mol Biol (2000) 0.91

[Electron microscopy studies on the occurrence of cilia in meningiomas]. Virchows Arch Pathol Anat Physiol Klin Med (1966) 0.90

Lipoxygenase product formation and cell adhesion during neutrophil-glomerular endothelial cell interaction. Am J Physiol (1995) 0.90

Role of tetrahydrobiopterin availability in the regulation of nitric-oxide synthase expression in human mesangial cells. J Biol Chem (1996) 0.90

Lack of carboxyl-terminal tyrosine distinguishes the B*2706-bound peptide repertoire from those of B*2704 and other HLA-B27 subtypes associated with ankylosing spondylitis. Tissue Antigens (1997) 0.90

Correction of hypertension by normalization of endothelial levels of fibroblast growth factor and nitric oxide synthase in spontaneously hypertensive rats. Proc Natl Acad Sci U S A (1996) 0.90

The same natural ligand is involved in allorecognition of multiple HLA-B27 subtypes by a single T cell clone: role of peptide and the MHC molecule in alloreactivity. J Immunol (1998) 0.90

Transcription factor AP-2 regulates human apolipoprotein E gene expression in astrocytoma cells. J Neurosci (1996) 0.89

Regulation of cyclooxygenase-2 expression by nitric oxide in cells. Antioxid Redox Signal (2001) 0.89

Limited diversity of peptides related to an alloreactive T cell epitope in the HLA-B27-bound peptide repertoire results from restrictions at multiple steps along the processing-loading pathway. J Immunol (2000) 0.89

Reversion of mtDNA depletion in a patient with TK2 deficiency. Neurology (2003) 0.89

Adenosine induces mesangial cell contraction by an A1-type receptor. Kidney Int (1989) 0.89

Regulation of inducible nitric oxide synthase expression in rat mesangial cells and isolated glomeruli. Kidney Int (1995) 0.89

Transcriptional induction of endothelial nitric oxide gene by cyclosporine A. A role for activator protein-1. J Biol Chem (2000) 0.89

Protective effect of steroids on liver ischemia. Am Surg (1975) 0.88

Actions of cyclosporin A on cultured rat mesangial cells. Kidney Int (1989) 0.88

Nitric oxide: from discovery to the clinic. Trends Pharmacol Sci (1998) 0.88

Interleukin-13 inhibits inducible nitric oxide synthase expression in human mesangial cells. Biochem J (1996) 0.88

Cytosolic levels of TFF1/pS2 in breast cancer: Their relationship with clinical-pathological parameters and their prognostic significance. Breast Cancer Res Treat (2005) 0.88

Reaction of peroxynitrite with oxyhaemoglobin: interference with photometrical determination of nitric oxide. Biochem J (1994) 0.88

The carbamoyl-phosphate synthetase of Pyrococcus furiosus is enzymologically and structurally a carbamate kinase. J Biol Chem (1999) 0.87

Differential effects of the tricyclic antidepressant amoxapine on glycine uptake mediated by the recombinant GLYT1 and GLYT2 glycine transporters. Br J Pharmacol (2000) 0.87

Intra- and extracellular expression of an scFv antibody fragment in E. coli: effect of bacterial strains and pathway engineering using GroES/L chaperonins. Biotechniques (1994) 0.87

The glycine receptor: pharmacological studies and mathematical modeling of the allosteric interaction between the glycine- and strychnine-binding sites. Mol Pharmacol (1986) 0.87

Structural features of the plasmid pMV158-encoded transcriptional repressor CopG, a protein sharing similarities with both helix-turn-helix and beta-sheet DNA binding proteins. Proteins (1998) 0.87

Characterization of neuronal amino acid transporters: uptake of nitric oxide synthase inhibitors and implication for their biological effects. J Neurochem (1995) 0.87

Giant cell tumour of bone: new treatments in development. Clin Transl Oncol (2015) 0.87

Purification and characterization of paraoxon hydrolase from rat liver. Biochem J (1997) 0.87

Apolipoprotein E forms stable complexes with recombinant Alzheimer's disease beta-amyloid precursor protein. Biochem J (1997) 0.87

Penicillinase producing strains of Neisseria gonorrhoeae in Madrid. Genitourin Med (1985) 0.85

N-Acetyl-L-glutamate kinase from Escherichia coli: cloning of the gene, purification and crystallization of the recombinant enzyme and preliminary X-ray analysis of the free and ligand-bound forms. Acta Crystallogr D Biol Crystallogr (1999) 0.85